In Silico Analysis of Six Known Leishmania major Antigens and In Vitro Evaluation of Specific Epitopes Eliciting HLA-A2 Restricted CD8 T Cell Response

Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis

(2010) Hiro Goto et al.   Expert Review of Anti-Infective Therapy

Vaccines and vaccination strategies against human cutaneous leishmaniasis

(2010) Ifeoma Okwor et al.   Human vaccines & immunotherapeutics

CD8 Cells of Patients with Diffuse Cutaneous Leishmaniasis Display Functional Exhaustion: The Latter Is Reversed, In Vitro, by TLR2 Agonists

(2010) Joselín Hernández-Ruiz et al.   PLoS Neglected Tropical Diseases

CD8+ T Cells as a Source of IFN-γ Production in Human Cutaneous Leishmaniasis

(2010) Mahmoud Nateghi Rostami et al.   PLoS Neglected Tropical Diseases

Cutaneous and mucocutaneous leishmaniasis

(2009) Consuelo V. David et al.   Dermatologic Therapy

Recruitment of CD8+T cells expressing granzyme A is associated with lesion progression in human cutaneous leishmaniasis

(2009) D. R. FARIA et al.   PARASITE IMMUNOLOGY

Mining the Leishmania genome for novel antigens and vaccine candidates

(2009) Carla Herrera-Najera et al.   PROTEOMICS

Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis

(2009) Amir Mizbani et al.   VACCINE

Identification of new cytotoxic T-lymphocyte epitopes from cancer testis antigen HCA587

(2008) Qiao Xing et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

HLA class I supertypes: a revised and updated classification

(2008) John Sidney et al.   BMC IMMUNOLOGY

An in silico immunological approach for prediction of CD8+ T cell epitopes of Leishmania major proteins in susceptible BALB/c and resistant C57BL/6 murine models of infection

(2008) F.Z. Guerfali et al.   INFECTION GENETICS AND EVOLUTION

Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model

(2008) R. Gomes et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: Correlation with IFN-γ and cytolytic activity by CD8+ T cells

(2008) Daniela M. Resende et al.   VACCINE

Vaccines for leishmaniasis in the fore coming 25 years

(2008) Clarisa B. Palatnik-de-Sousa   VACCINE

A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis

(2008) Connor Carson et al.   VACCINE